WSJ : Google Invests $1 Billion in Exchange Giant CME, Strikes Cloud Deal

Google Invests $1 Billion in Exchange Giant CME, Strikes Cloud Deal
Tie-up gives Google’s cloud arm a prize client in financial services

Alphabet Inc.’s GOOG 0.64% Google has invested $1 billion in futures-exchange giant CME CME -0.07% Group Inc. and struck a deal to move the company’s core trading systems to the cloud.

Under the deal, the technology giant’s Google Cloud unit would eventually power markets that handle trillions of dollars in trades each day.

The companies said Thursday that their 10-year partnership would allow CME to bring on new users faster, streamline operations and develop new tools with Google technology, such as artificial-intelligence software for monitoring market risks.

In cloud computing, companies outsource computer processing and data storage to technology firms, rather than trying to run such systems themselves.

Cloud providers such as Amazon.com Inc., Google and Microsoft Corp. have been jockeying for position in the financial-services sector, which has been slower to adopt cloud computing than other industries. The reluctance stems in part from the tight regulatory oversight of banks and exchanges, as well as concerns over breaches of sensitive client data.

The CME deal gives Google Cloud a prize client in the sector. With a market capitalization of $79.2 billion, CME is the world’s most valuable exchange operator, a title it recently reclaimed from Hong Kong Exchanges & Clearing Ltd. The Chicago-based company runs an array of markets, from crude oil to gold to stock-market futures.

Google Cloud is the fourth-largest cloud provider, taking 6.1% of global cloud-infrastructure revenues last year, according to research firm Gartner Inc. The biggest player is Amazon, whose market share last year was more than 40%, followed by Microsoft and Alibaba Group Holding Ltd. , Gartner data shows.

Alongside the cloud deal, Google made a $1 billion equity investment in nonvoting convertible preferred CME Group stock, the companies said. In an interview, Google Cloud Chief Executive Thomas Kurian called the investment “a reflection of our commitment to the transformation of the financial system, not just to one company’s infrastructure.”

Moving CME’s trading systems to the cloud will pose technical challenges beyond those of a typical corporate cloud project.

Exchanges like CME handle a vast number of price quotes and trades, many submitted by high-speed trading firms accustomed to having the exchanges’ systems process orders in millionths of a second. And if an exchange goes down, it isn’t just an inconvenience, but can have ripple effects throughout the financial markets.

Despite such difficulties, exchanges have begun to dip their toes into cloud technology. Nasdaq Inc. said last year that it planned to move its markets to the cloud over the next decade.

Amazon has also been eyeing the exchange business. The tech giant’s cloud-computing arm, Amazon Web Services, completed a pilot project last year with Singapore Exchange Ltd. and European market operator Aquis Exchange PLC to prove it was possible to run an exchange capable of handling ultrafast, high-volume trading on AWS technology.

CME will begin moving its technology infrastructure to Google Cloud next year, the companies said. Initially, the companies plan to focus on CME’s data and clearing services, which aren’t as sensitive to speed as the core trading systems. Clearing is the behind-the-scenes process of settling transactions and moving money between market participants after trades. Eventually, the plan calls for moving all of CME’s markets onto the cloud.

“I wanted to be under a technology umbrella that has the bandwidth to allow me to grow my business,” CME Chairman and Chief Executive Terrence Duffy said in an interview. “I’m good at transactional businesses, myself and my team. Google is really good at technology. I think it’s a marriage made in heaven.”

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • RMNI -27.9%, UPLD -25.9%, LSPD -19.1%, SPWR -11.1%, LCI -10.9% (also announces restructuring plan), MRNA -10.8%, MTW -10.1%, MGNI -9.4%, QRVO -9.3% (also acquires United Silicon Carbide), QUOT -9.2%, MDU -9%, TNDM -8.8%, ELF -8.8%, SKLZ -8.2%, DOCN -8%, NEO -7.6%, ROKU -7.4%, CLR -7.3% (also to acquire Permian Basin assets from PXD for $3.25 bln), QRTEA -7.2%, RCII -6.4%, TPC -6.1%, MTTR -5.9%, WHD -5.7%, FIS -5.3%, BLL -5.1%, PENN -5%, COMM -4.8%, W -4.8%, BBIO -4.7%, CDAY -4.5%, SWM -4.4%, GPRE -4.3%, TRUP -3.7%, ALL -3.7%, LITE -3.6%, DLX -3.5%, VNDA -3.3%, LXP -3.3%, STRA -2.9%, NRG -2.8%, FSR -2.4%, VVV -2.4%, APTV -2.4%, KTOS -2.3%, ALE -2.2%, REGI -2.1%, STAA -2.1%, LNC -2.1%, APD -2.1%, DISH -2%, CTXS -1.9%, BLI -1.8%, WMS -1.8%, RVLV -1.7%, EQIX -1.7%, RGR -1.6%, AES -1.6%, CF -1.5%, CF -1.5%, HWM -1.5%, IRWD -1.5%, INSG -1.4%, OSUR -1.3%, SJI -1.3%, ITT -1.3%, GOLF -1.3%, PLMR -1.2%, AEE -1.2%, SLF -1.2%, VNT -1.2%, CCOI -1.2%, REYN -1.2%, PWR -1.1%, NTCT -1.1%, GTN -1%, DEN -1%, VMC -1%

Other news:

  • CMRX -26.9% (topline data from its 50-patient efficacy analysis of ONC201)
  • ANIP -6.6% (prices offering of 1.5 mln shares of common stock at $50.00 per share)
  • FIS -5.8% (announces updated capital allocation strategy; increases expected annual dividend growth rate)
  • STAG -2.9% (prices offering of 8 mln shares of common stock for gross proceeds of $340 mln)
  • APTO -2% (entered into an exclusive license agreement with Hanmi Pharmaceutical to develop and commercialize HM43239)
  • FRBK -1% (receives letters from Driver Management)

Analyst comments:

  • ASAN -2.6% (downgraded to Hold from Buy at Jefferies)
  • AMRC -1.8% (downgraded to Neutral from Overweight at Piper Sandler)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • QNST +23.5%, CCRN +20.8%, AHCO +13.8%, HMHC +11.6%, MAXR +10.9%, SUPN +9.9%, MLNK +9.9%, QCOM +9.6%, CWAN +8.9%, GDDY +8.6%, WK +7.9%, BLDR +7.9%, SITM +7.6%, OCDX +7.3%, OPRT +6.8%, VSTO +6.8%, CUTR +6.7%, SSYS +6.7%, FSLY +6.3%, GOGO +5.7%, VAPO +5.3%, PLNT +5.3%, RPD +4.8%, QLYS +4.6%, BKNG +4.6%, ONEM +4.6%, ALB +4.5%, YELL +4.4%, GIL +4.1%, LNTH +4%, HIMX +3.9%, PZZA +3.8%, APA +3.7% (also increases dividend), INFN +3.6%, ECPG +3.6%, ACIW +3.6%, GEL +3.6%, MGM +3.5%, LUMN +3.4%, ICLR +3.4%, PETQ +3.4%, DIOD +3.3%, GFL +3.3%, SRPT +3.2%, NUS +3.2%, WBX +3.2%, AG +3.1%, NVMI +3.1%, VMEO +3%, IIPR +3%, NVST +2.8%, VG +2.8%, EA +2.7%, SNN +2.6%, REGN +2.6%, TTWO +2.4%, EQH +2.4%, KW +2.3%, TXG +2.3%, MRO +2.2%, CNQ +2.2%, H +2.1%, TRMB +2.1%, CI +2.1%, MUR +2.1%, WLL +2%, BDX +2%, BKE +1.8%, CTVA +1.7%, ZTS +1.7%, CYBR +1.7%, PH +1.6%, EPAM +1.5%, SHYF +1.5%, ET +1.4%, CORT +1.4%, BLKB +1.3%, TGP +1.3%, ABC +1.3%, SWN +1.2%, HL +1.2%, ADPT +1.1%, XRAY +1.1%, VIAC +1.1%, DNB +1.1%, ORCC +1%, DIN +1%, CNP +1%, KTB +1%

Other news:

  • NPTN +34% (agrees to be acquired by Lumentum (LITE) for $16.00/share in cash)
  • QFTA +5.1% (TradeStation Group to become public company through business combination with Quantum FinTech)
  • TMDX +4.7% (top-line results from US randomized OCS DCD Heart Trial)
  • MNRL +3.8% (announces accretive DJ Basin acquisition)
  • CENX +3.3% (commences construction of new low-carbon billet casthouse)
  • ZG +2.5% (Cathie Wood purchased shares of ZG amid stock drop, according to Reuters)
  • TTWO +2.4% (cancels Hangar 13 project, according to Bloomberg)
  • GTH +2.2% (proprietary large-panel product, Onco PanScan, has obtained the CE mar)
  • OYST +1.9% (TYRVAYA Nasal Spray 0.03 mg now available at US regional wholesalers for distribution to pharmacies)
  • PRFT +1.3% (convertible notes offering)
  • EPZM +1.3% (FDA has granted Fast Track designation to EZM0414) 
  • FUBO +1.2% (is now live in the mobile sports betting market with launch of Fubo Sportsbook in Iowa)
  • NDAQ +1.2% (reports October metrics)

Analyst comments:

  • CPRI +5.7% (upgraded to Overweight from Neutral at JP Morgan)
  • KNBE +4.5% (upgraded to Buy from Neutral at Goldman)
  • RS +1.7% (upgraded to Buy from Neutral at Goldman)

FT : EU should put the brakes on its chips strategy

EU should put the brakes on its chips strategy
Driving high-end production back home may do little to ease shortages that have hit growth

Hello from a rainy and increasingly grey Frankfurt, where we’re covering the latest round of results from Germany’s big industrial players.

Among a set of rosy figures from premium carmakers, BMW’s have stood out. While rival Daimler saw quarterly sales drop 32 per cent because of the supply chain crisis, the Munich-based brand only suffered a 12 per cent drop in the same period, and registered a whopping 42 per cent rise in net profits.

Boss Oliver Zipse told all who would listen that this was down to BMW’s superior supply chain management — a view echoed by analysts. It somewhat puts paid to the idea — in vogue in Brussels and parroted by the auto lobby, the European Automobile Manufacturers’ Association (ACEA) which Zipse chairs — that proximity to semiconductor foundries has anything to do with securing supply of the scarce chips.

This vexing topic is the focus of today’s main piece. We’ve been out to meet the chipmakers with existing bases in Europe — such as Infineon, GlobalFoundries and Bosch — and found few who are convinced the EU’s plans to reshore production will achieve its most vocal proponents’ aims. Given the subsidies on offer, they are unlikely to voice their scepticism out loud, at least not before it is too late.

Brussels’ chips plan won’t solve carmakers’ woes
Earlier this year, roughly around the time that the chief executive of a German premium manufacturer assured the Financial Times that his company had “full visibility” of its supply chain, a sales executive at Europe’s largest semiconductor site received a call.

On the line to the Dresden branch of GlobalFoundries was a purchasing manager from a large carmaker — a rare occurrence, given that auto groups generally leave their tier-one suppliers to look after the mundane business of semiconductor procurement.

The question from the car executive, voiced with a nervous tone, foretold the crisis that was about to envelop the entire sector. “Would you consider running your fabs overnight and on weekends?”

Those familiar with the semiconductor industry know that its profitability hinges on “utilisation” rates, or how often a company can run its factories around the clock. In Europe, where personnel and energy costs are high (GlobalFoundries’ Dresden facility uses the equivalent electricity to roughly 200,000 households), this is especially true.

No fabrication plant survives for very long with idle capacity. In fact, large amounts of research-and-development spend is geared towards reducing the amount of downtime needed for equipment repairs. After a short, pandemic-induced lull, GlobalFoundries has been running its fabs at full pelt from August 2020, its boss recently told CNBC.

The car executive’s ignorance characterises, insiders say, the ill-informed response to the chips crisis from corners of both European industry and politics.

A shortage of semiconductors has hit Europe’s manufacturers hard. Nowhere more so than in the region’s economic engine, Germany, where automakers contribute sizeable chunks to gross domestic product growth. The latest official figures show German manufacturing output fell 4 per cent in August compared with July, with production of motor vehicles and trailers slumping almost a fifth because of supply chain woes.

The shortage has also underscored the degree to which the rest of the world relies on Taiwanese foundries for crucial chips. One hardly has to be an expert on geopolitics to appreciate that the territory is not the most stable place on earth.

In September, the European Commission acted. President Ursula von der Leyen proposed a “European Chips Act”, arguing that reshoring production of semiconductors, the vast majority of which are manufactured in Asia, was a matter of “tech sovereignty”. 

While EU internal market commissioner Thierry Breton helpfully clarified that “the idea is not to produce everything on our own here in Europe”, (good luck making substrate manufacturing economical in the developed world) it remains the EU’s ambition to double its semiconductor market share by the end of the decade, by supporting the building and expansion of cutting-edge fabs on the continent.

Trade Secrets has long had its doubts about the strategy.

The problem with this plan, as we see it and as a cogent piece from Niclas Poitiers at Bruegel points out, is threefold.

The first, as underscored by the boss of Europe’s largest semiconductor company, Infineon, is that the biggest buyers of chips are elsewhere. The automotive sector accounts for roughly 8 per cent of the total semiconductor market. No amount of proximity to the car industry, for example, will make up for the fact that Apple and Samsung and the like are at least eight places ahead in the pecking order (as a purchasing executive at VW put it to us).

Second, the amount of investment needed is eye-watering. Taiwan’s chips giant TSMC will spend $100bn to expand its footprint over the next three years. The EU expects to invest up to €30bn by 2030. As TSMC’s American founder put it to our colleagues at Nikkei, “even after you spend hundreds of billions of dollars, you will still find the supply chain to be incomplete, and you will find that it will be very high cost, much higher costs than what you currently have”. That EU funding pool will have to get a whole lot bigger if it is to make much difference.

Third, and most importantly, there is a mismatch between the type of investment that interests the EU — the most advanced chip production facilities — and the semiconductors that Europe’s automakers are desperate to procure.

As part of its “2030 Digital Compass” plan, the bloc says it wants to build “manufacturing capacities below 5nm nodes, aiming at 2nm and 10 times more energy efficient than today”.

But two-nanometre chips are hardly used by carmakers. Modern cars are filled with hundreds of much larger chips, mostly low-margin power, radar and memory semiconductors, which make the windows go up and down and help the GPS work. In a two-tonne, 4.5-metre long SUV, chip size and weight are hardly a factor. Cost is.

“We have nobody who makes phones, we have nobody who makes PCs,” Jalal Bagherli, chief executive of Dialog Semiconductor, told the FT, referring to Europe. Investing in bleeding-edge processing chips, he added, “doesn’t make a lot of economic sense to me”.

That hasn’t stopped those who see subsidies coming down the line laying out their stalls. In September, car registrations in Europe dropped almost a quarter to the lowest level in more than 25 years. “In order to avoid this from happening again in the future, Europe also needs to come up with a strategic plan to increase the production of semiconductors in the EU,” the industry’s Brussels lobby, the ACEA, said last month.

Yet, as we mentioned earlier, their current president seems to have managed the crisis well despite relying on Asian suppliers — suggesting that a better understanding of the semiconductor market, and one’s place within it, is a far more effective solution than splashing the cash from Brussels.

“We know exactly who our suppliers are, not only on the tier-one level but right down to the raw materials,” Zipse told journalists on Wednesday. While he declined to comment on whether BMW was paying more for its chips than others, he did say that the company “always had a fair agreement in terms of how we deal with suppliers . . . that’s paying off now”. 

As well as being somewhat misdirected, there is every chance that Breton and the EU’s ambitions will backfire.

Automotive companies are already considerably over-ordering chips. Infineon’s chief told the FT last month that “current orders look more like 110m to 120m cars [per year]”, when 80m-odd are expected to be sold in 2022, according to data firm IHS Markit.

Stacy Rasgon, a forensic semiconductor analyst at Bernstein in the US, said chip orders by automotive customers were 42 per cent “above trend” last quarter, meaning above the amount of cars actually being produced.


Investing in semiconductor capacity for political “bragging rights” (as one semis executive termed it) is risky enough. Investing in it based on current demand might be detrimental to existing Europe-based fabs, leaving them with the surplus capacity they so desperately try to avoid.

In its prospectus before going public this week on the Nasdaq in New York, GlobalFoundries had a telling warning to investors about its business model. “If we overestimate customer demand . . . we could experience underutilisation of capacity at these facilities without a corresponding reduction in fixed costs.”

We doubt that’s a message well understood by their customers in the car industry, or lawmakers in Brussels.

FT : Former Binance US chief Brian Brooks to lead crypto miner Bitfury

Former Binance US chief Brian Brooks to lead crypto miner Bitfury
China’s crackdown has delivered a windfall to international groups that mint digital tokens

Bitfury has named former Binance US boss Brian Brooks as chief executive, with the former financial regulator taking the reins of one of the world’s biggest crypto mining outfits at a time when the industry is booming.

Brooks will replace Bitfury founder Valery Vavilov, who will become the company’s “chief vision officer,” tasked with developing new projects.

The appointment by the Amsterdam-based company comes after China earlier this year banned cryptocurrency mining, the energy intensive process in which new digital tokens are created. The move delivered a windfall to international companies that stepped in to fill the capacity void.

Latvian-born Vavilov founded Bitfury in 2011 as a bitcoin mining operation, but he has expanded the business to include infrastructure projects such as data centre operations, computer chips and software development for the crypto industry.

Brooks is joining Bitfury after he in August abruptly exited Binance US after only three months in the job. Binance US is an affiliate of the sprawling Binance crypto exchange that has come under severe pressure from key regulators around the world.

Brooks said he was “highly confident” his tenure would last longer at Bitfury, telling the Financial Times he expected to “gel better” with Vavilov than his former employer.

“The exchange business is currently profitable but it isn’t necessarily where innovation is happening,” Brooks said, adding that Bitfury’s status as the only mining chip producer outside China gave it an edge.

Vavilov said he found an “instant energy fit” with Brooks, who until January worked as acting head of the US banking regulator the Office of the Comptroller of the Currency. He had also previously worked at crypto exchange Coinbase as its chief legal officer.

“We learnt how to build successful companies and also markets and infrastructure around it. But all of this is taking a long time and I’ve been looking for a new chief for three years,” Vavilov said.

Bitcoin mining has drawn concerns about its negative impact on the environment. The industry consumes more electricity than the Netherlands and slightly less than the United Arab Emirates, according to the Cambridge Bitcoin Electricity Consumption Index.

Brooks acknowledged that “Bitcoin miners are seen to be posing an environmental problem”. However, he said Bitfury had taken measures that would reduce the industry’s climate impact. For example, Bitfury designed a technology to make cooling computers and data centres more efficient, cutting down the activity’s environmental footprint.

The reshuffle at the top comes as Bitfury is gearing up for a fundraising round as it seeks to build new mining centres around the world. The company achieved a valuation of $1bn at its 2018 funding round, a figure that may be exceeded this time. Core Scientific, another crypto mining and data centre specialist, was recently valued at $4.3bn including net debt in a deal to merge with a blank-cheque company.

“We are looking at both venture capital and [a stock market] listing. Conditions in the venture capital market are very favourable right now so we’ll probably go down that route but we are considering both,” Brooks said.

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • CCRN +26.2%, QNST +22.7%, CUTR +12.7%, SUPN +9.9%, MLNK +9.9%, FSLY +9.7%, CWAN +8.9%, MAXR +8.8%, GDDY +8.6%, QCOM +8.2%, WK +7.9%, SITM +7.8%, OCDX +7.3%, OPRT +6.8%, GFL +6.4%, VSTO +6%, YELL +5.6%, NUS +5.4%, VAPO +5.3%, MGM +4.7%, ALB +4.3%, DIOD +4.3%, QLYS +4.2%, RYN +4.1%, BKNG +4%, TRN +3.8%, EQH +3.8%, ECPG +3.7%, GEL +3.6%, ICLR +3.4%, PETQ +3.4%, CENX +3.3%, VMEO +3%, TXG +3%, AES +2.8%, NVST +2.8%, LUMN +2.8%, EA +2.8%, PING +2.7%, QFTA +2.5%, RGLD +2.4%, COLD +2.3%, KW +2.3%, ONEM +2.3%, ZG +2.2%, GTH +2.2%, H +2.1%, HBM +2%, WLL +2%, OYST +1.9%, STAA +1.9%, MRO +1.9%, SNN +1.9%, SRPT +1.8%, MUR +1.8%, FUBO +1.7%, HL +1.7%, APTO +1.6%, ET +1.6%, CTVA +1.5%, MATX +1.5%, CORT +1.4%, HRTX +1.4%, PTC +1.4%, BLKB +1.3%, TGP +1.3%, GEO +1.3%, INFN +1.2%, LNC +1.1%, ADPT +1.1%, XRAY +1.1%, PRFT +1%, MET +1%, EPR +1%, ORCC +1%, NDAQ +0.9%, TTWO +0.8%, IBM +0.8%
  • Gapping down:
    • UPLD -23.7%, RMNI -23%, SPWR -12.7%, TNDM -10.3%, MTW -10.1%, SWM -10%, MGNI -9.4%, QRVO -9.2%, MDU -9%, QUOT -8.1%, LCI -8.1%, MTTR -8.1%, ROKU -7.2%, SKLZ -6.8%, CLR -6.7%, TPC -6.1%, RCII -5.8%, WHD -5.7%, KTOS -5.1%, TRUP -4.6%, ANIP -4.5%, CDAY -4.5%, REGI -4.3%, RVLV -4.1%, ELF -3.6%, DLX -3.5%, WCC -3.4%, ALL -3.3%, LXP -3.3%, STAG -3.1%, EQIX -3.1%, SPXC -3%, CAKE -2.9%, VVV -2.4%, BLL -2.4%, INSG -2.1%, CF -1.9%, HST -1.8%, HII -1.7%, RGR -1.6%, HUBS -1.5%, DISH -1.4%, FRBK -1.3%, SJI -1.3%, FSR -1.3%, ITT -1.3%, SAND -1.3%, PLMR -1.2%, SLF -1.2%, VNT -1.2%

FT : Novartis to sell Roche stake worth $21bn

Novartis to sell Roche stake worth $21bn
Swiss drugmakers to end 20-year shareholding between the crosstown rivals

Swiss drugmaker Novartis is to sell its stake in domestic rival Roche, bringing an end to a two-decade old investment now worth $21bn.

Novartis said in a statement on Thursday that Roche would repurchase the stake it holds in its competitor, which is also headquartered in the Swiss city of Basel.

Novartis chief executive Vas Narasimhan said the drugmaker’s decision to ditch the stake was “consistent with our strategic focus”, and that it planned to deploy the proceeds to “continue to reimagine medicine”.

The agreement will see Roche repurchase the 53.3m shares Novartis has in its rival, using debt to finance the deal.

In a statement Roche said that the transaction would lead “to the disentanglement of the two competitors” and result in the company “regain[ing] full strategic flexibility”.

Following the deal, Roche chair Christoph Franz said the drugmaker would be “better positioned strategically in the future to provide life-saving medicines and diagnostics to people around the world”.

The holding Novartis has in Roche dates back to 2001, when it began amassing it for a total cost of $5bn. The investment had yielded dividends of more than $6bn, Novartis said.

Narasimhan has sought to refocus Novartis since taking the helm in 2018, spinning off its eye-care unit and last week unveiling a strategic review for its generics division Sandoz, which could include a sale. It has said it will provide an update by the end of next year.

SoftBank this year acquired a stake worth about $5bn in Roche.